Pathways in the regulation of clinical stem cell research: harmonization, “double discourse” and alter-standardization

In this presentation, Dr. Vasen explores the regulatory developments in stem cell medicine in the main national jurisdictions. He claims that the field is undergoing a process of diversification and indetify three pathways of regulatory development: international harmonization, "double discourse" and alter-standardization. The presentation is based on previous work published together with Achim Rosemann, Gabriela Bortz, and Margaret Sleeboom-Faulkner. PICTURE: Giulia Musella, Woman on a flower meadow.